| For: | Moura CS, Etingin A, Lukusa L, Singh H, Narula N, Targownik LE, Leung Y, Zezos P, Polewiczowska-Nowak B, Afif W, Bernatsky S. Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics vs biosimilars. World J Gastroenterol 2026; 32(9): 114580 [PMID: 41810446 DOI: 10.3748/wjg.v32.i9.114580] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v32/i9/114580.htm |
| Number | Citing Articles |
| 1 |
Dong Hyun Kim, Seung Min Hong, Seung Yong Shin, June Hwa Bae, Eun Mi Song, Ji Eun Kim, Young Joo Yang, Jiyoung Yoon, Sang-Bum Kang, Eun Soo Kim, Seong-Eun Kim, Seong-Jung Kim, Jun Lee, Soo-Young Na, Soo Jung Park, Sang Hyoung Park, Myung Ha Kim, Miyoung Choi, Jong Lyul Lee, Se-Jin Baek, Won Moon, Sung-Ae Jung. KASID Guidelines for the Medical Treatment of Ulcerative Colitis: 2026. The Korean Journal of Gastroenterology 2026; 86(4) doi: 10.4166/kjg.2026.091
|
| 2 |
Chuong Dinh Nguyen, Luan Minh Dang. Biosimilars in inflammatory bowel disease: Beyond evidence, toward trust and implementation. World Journal of Gastroenterology 2026; 32(28): 119462 doi: 10.3748/wjg.119462
|
| 3 |
Anthony Vignone, Simone Di Cola, Flaminia Ferri, Francesco Covotta, Lewis J. Frey, Wing-Kin Syn, Domenico Alvaro, Vincenzo Cardinale. Unmet Needs in Primary Sclerosing Cholangitis Associated with Inflammatory Bowel Disease: A Comprehensive Review. Livers 2026; 6(4) doi: 10.3390/livers6040075
|